Novogene Co., Ltd.

Market Cap: Mid Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: CNE1000052X3

CNY

15.57

-0.2 (-1.27%)

Feb 11

SHG

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Novogene Co., Ltd.

Why is Novogene Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 5.98% and Operating profit at -0.99% over the last 5 years

The company has declared negative results in Mar'2025 after 2 consecutive positive quarters

INTEREST(HY) At CNY 0.79 MM has Grown at 16.72%
DEBTORS TURNOVER RATIO(HY) Lowest at 2.8%

Underperformed the market in the last 1 year

The stock has generated a return of 5.20% in the last 1 year, much lower than market (China Shanghai Composite) returns of 24.27%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Novogene Co., Ltd. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Novogene Co., Ltd.

5.2%

0.64

48.91%

China Shanghai Composite

24.27%

1.73

14.05%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

5.98%

EBIT Growth (5y)

-0.99%

EBIT to Interest (avg)

78.60

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.58

Sales to Capital Employed (avg)

0.86

Tax Ratio

8.59%

Dividend Payout Ratio

10.40%

Pledged Shares

Institutional Holding

ROCE (avg)

15.78%

ROE (avg)

9.34%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.42

EV to EBIT

27.08

EV to EBITDA

13.93

EV to Capital Employed

4.47

EV to Sales

2.19

PEG Ratio

Dividend Yield

0.33%

ROCE (Latest)

16.52%

ROE (Latest)

7.26%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bearish

Bollinger Bands

Bullish

Mildly Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 338.55 MM

RAW MATERIAL COST(Y)

Fallen by 1.31% (YoY

-4What is not working for the Company

INTEREST(HY)

At CNY 0.79 MM has Grown at 16.72%

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.8%

Here's what is working for Novogene Co., Ltd.

Operating Cash Flow

Highest at CNY 338.55 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Raw Material Cost

Fallen by 1.31% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Novogene Co., Ltd.

Interest

At CNY 0.79 MM has Grown at 16.72%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debtors Turnover Ratio

Lowest at 2.8%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio